[1] Kojima K, Vacanti CA. Tissue engineering in the trachea. Anat Rec (Hoboken). 2014;297(1):44-50.[2] Todeschi MR, El Backly R, Capelli C, et al. Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration. Stem Cells Dev. 2015;24(13):1570-1581.[3] Yang Y, Tao C, Zhao D, et al. EMF acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes. Bioelectromagnetics. 2010;31(4):277-285.[4] Tamaddon M, Burrows M, Ferreira SA, et al. Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro. Sci Rep. 2017;7:43519.[5] Voss A, McCarthy MB, Hoberman A, et al. Extracellular Matrix of Current Biological Scaffolds Promotes the Differentiation Potential of Mesenchymal Stem Cells. Arthroscopy. 2016; 32(11):2381-2392.[6] Liu Y, Chen T, Du F, et al. Single-Layer Graphene Enhances the Osteogenic Differentiation of Human Mesenchymal Stem Cells In Vitro and In Vivo. J Biomed Nanotechnol. 2016;12(6): 1270-1284.[7] Matic I, Antunovic M, Brkic S, et al. Expression of OCT-4 and SOX-2 in Bone Marrow-Derived Human Mesenchymal Stem Cells during Osteogenic Differentiation. Open Access Maced J Med Sci. 2016;4(1):9-16.[8] Ciuffreda MC, Malpasso G, Musarò P, et al. Protocols for in vitro Differentiation of Human Mesenchymal Stem Cells into Osteogenic, Chondrogenic and Adipogenic Lineages. Methods Mol Biol. 2016;1416:149-158.[9] Qin Y, Wang L, Gao Z, et al. Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo. Sci Rep. 2016;6:21961.[10] Zhang TY, Huang B, Yuan ZY, et al. Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection. Nanomedicine. 2014; 10(1):257-267.[11] Seguin A, Baccari S, Holder-Espinasse M, et al. Tracheal regeneration: evidence of bone marrow mesenchymal stem cell involvement. J Thorac Cardiovasc Surg. 2013;145(5): 1297-1304.[12] 崔崟,史定伟,谢幼专,等. 可携带骨髓干细胞的生物型空心钉内固定治疗股骨颈骨折的临床分析[J]. 中国骨与关节损伤杂志, 2014,29(12):1196-1198.[13] 梁建基,何智勇,刘康,等. 关节腔注射自体骨髓间充质干细胞治疗轻中度骨性关节炎[J]. 中国组织工程研究, 2015, 19(14): 2216-2223. [14] Vega A, Martín-Ferrero MA, Del Canto F, et al. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015;99(8):1681-1690.[15] Jang YO, Kim YJ, Baik SK, et al. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 2014;34(1):33-41.[16] Xu L, Gong Y, Wang B, et al. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. J Gastroenterol Hepatol. 2014;29(8):1620-1628.[17] Bian S, Zhang L, Duan L, et al. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl). 2014;92(4):387-397.[18] Williams AR, Hatzistergos KE, Addicott B, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2013;127(2):213-223.[19] 吴利安,王从毅,杨文,等.自体骨髓间充质干细胞移植对兔角膜碱烧伤炎症反应的抑制作用[J].中华实验眼科杂志, 2015, 33(9): 789-804.[20] Belingheri M, Lazzari L, Parazzi V, et al. Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis. Biologicals. 2013;41(6): 439-445.[21] Bueno C, Roldan M, Anguita E, et al. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica. 2014;99(7):1168-1175.[22] Zhao K, Lou R, Huang F, et al. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21(1):97-104.[23] Copland IB, Qayed M, Garcia MA, et al. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune- Suppressive Activity. Biol Blood Marrow Transplant. 2015; 21(5):934-940.[24] Ren C, Geng RL, Ge W, et al. An observational study of autologous bone marrow-derived stem cells transplantation in seven patients with nervous system diseases: a 2-year follow-up. Cell Biochem Biophys. 2014;69(1):179-187.[25] Yang C, Liu H, Liu D. Mutant hypoxia-inducible factor 1α modified bone marrow mesenchymal stem cells ameliorate cerebral ischemia. Int J Mol Med. 2014;34(6):1622-1628.[26] Tsai PJ, Wang HS, Lin CH, et al. Intraportal injection of insulin-producing cells generated from human bone marrow mesenchymal stem cells decreases blood glucose level in diabetic rats. Endocr Res. 2014;39(1):26-33.[27] 盛夏涵,曲禄瑶,蔡协艺,等.大鼠骨髓间充质干细胞与髁突软骨细胞共培养诱导软骨分化的实验研究[J].中国口腔颌面外科杂志, 2016,14(11):490-494.[28] Lu J, Fan Y, Gong X, et al. The Lineage Specification of Mesenchymal Stem Cells Is Directed by the Rate of Fluid Shear Stress. J Cell Physiol. 2016;231(8):1752-1760.[29] Liu G, Li Y, Sun J, et al. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng Part A. 2010;16(3):971-982.[30] Joseph M, Das M, Kanji S, et al. Retention of stemness and vasculogenic potential of human umbilical cord blood stem cells after repeated expansions on PES-nanofiber matrices. Biomaterials. 2014;35(30):8566-8575.[31] 钟晓红,王明刚,赵李平,等.骨髓间充质干细胞在糖尿病模型创面中向表皮细胞分化的初步研究[J].中国美容医学, 2010, 19(1): 65-67.[32] 徐胜利,周明,陈彪,等.神经营养因子基因修饰的神经干细胞在帕金森病大鼠模型中的治疗作用[J].中华老年医学杂志, 2010, 29(1):58-63.[33] 张可华,蔡哲.神经干细胞向多巴胺能神经元分化机制的研究进展[J].中国康复理论和实践, 2012,16(4): 314-318.[34] 陈亚男,刘辉,赵红斌,等.红景天苷诱导骨髓间充质干细胞向神经细胞定向分化的机制研究[J].药学学报, 2013,48(8): 1247-1252.[35] Ertan AB, Y?lgor P, Bayyurt B, et al. Effect of double growth factor release on cartilage tissue engineering. J Tissue Eng Regen Med. 2013;7(2):149-160.[36] Bussolati B, Camussi G. Adult stem cells and renal repair. J Nephrol. 2006;19(6):706-709.[37] Niess H, Bao Q, Conrad C, et al. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg. 2011;254(5):767-774.[38] Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem Cells. 2004;22(4):487-500.[39] Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999;181(1):67-73.[40] Reger RL, Tucker AH, Wolfe MR. Differentiation and characterization of human MSCs. Methods Mol Biol. 2008; 449:93-107.[41] 卓群豪,张伟娜,李舰,等. 膝关节腔内注射Sox9转染骨髓间充质干细胞修复膝关节骨关节炎[J]. 中国组织工程研究,2017,21(5): 736-741.[42] Maldonado M, Nam J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int. 2013;2013: 284873.[43] Kawamura K, Chu CR, Sobajima S, et al. Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures. Exp Hematol. 2005;33(8): 865-872.[44] Kondo M, Yamaoka K, Tanaka Y. Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditions. Int J Mol Sci. 2014;15(11):21270-21285.[45] Mara CS, Duarte AS, Sartori A, et al. Regulation of chondrogenesis by transforming growth factor-beta 3 and insulin-like growth factor-1 from human mesenchymal umbilical cord blood cells. J Rheumatol. 2010;37(7):1519-1526.[46] Mueller MB, Fischer M, Zellner J, et al. Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs. 2010;192(3):158-166. |